clinical trial · NCT07263178
A Study of Second- and Later-line Palliative Chemotherapy in Patients With Metastatic Colorectal Cancer.
Boryung Pharmaceutical Co., Ltd·—·recruiting·n = 1,000
Metastatic Colorectal CancerSecond and later-line palliative chemotherapy
brief summary
This study aims to comprehensively identify the various treatment patterns of second- or subsequent-line palliative chemotherapy used in patients with metastatic colorectal cancer who have experienced failure of first-line palliative chemotherapy and to evaluate the prognosis of each treatment.
started
Nov 7, 2025
primary completion
Dec 1, 2029
completion
Dec 1, 2029
last updated
Dec 4, 2025
official title
A Multi-center, Prospective, Observational Study to Assess the Treatment Patterns and Prognosis of Second and Later-line Palliative Chemotherapy in Patients With Metastatic Colorectal Cancer Who Failed First-line Palliative Chemotherapy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol